{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:18:57Z","timestamp":1783106337340,"version":"3.54.6"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["990706"],"award-info":[{"award-number":["990706"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jdiacomp.2024.108722","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T08:02:01Z","timestamp":1710230521000},"page":"108722","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"38","author":[{"given":"Ali","family":"Mahmoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Jalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Hamid","family":"Aghaee-Bakhtiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza Kazemi","family":"Oskuee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2024.108722_bb0005","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41419-019-1672-4","article-title":"Ets-1 deficiency alleviates nonalcoholic steatohepatitis via weakening TGF-\u03b21 signaling-mediated hepatocyte apoptosis","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5170402","article-title":"Pathogenesis of nonalcoholic Steatohepatitis: interactions between liver parenchymal and nonparenchymal cells","volume":"2016","author":"Magee","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0035","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0040","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3390\/ijms17122082","article-title":"Pathophysiology of non alcoholic fatty liver disease","volume":"17","author":"Petta","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/10799893.2020.1726952","article-title":"Inevitable role of TGF-\u03b21 in progression of nonalcoholic fatty liver disease","volume":"40","author":"Nair","year":"2020","journal-title":"J Recept Signal Transduction"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic Steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0055","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/nu14071331","article-title":"Investigation of the effect of curcumin on protein targets in NAFLD using bioinformatic analysis","volume":"14","author":"Mahmoudi","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3654660","article-title":"Target deconvolution of fenofibrate in nonalcoholic fatty liver disease using bioinformatics analysis","volume":"2021","author":"Mahmoudi","year":"2021","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0065","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.drudis.2022.05.007","article-title":"Impact of fenofibrate on NAFLD\/NASH: a genetic perspective","volume":"27","author":"Mahmoudi","year":"2022","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0070","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/jcp.30699","article-title":"The role of exosomal miRNA in nonalcoholic fatty liver disease","volume":"237","author":"Mahmoudi","year":"2022","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3350\/cmh.2020.0136","article-title":"Precision medicine in nonalcoholic fatty liver disease: new therapeutic insights from genetics and systems biology","volume":"26","author":"Sookoian","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0080","series-title":"NAFLD in children: new genes, new diagnostic modalities and new drugs","first-page":"517","volume":"16(9)","author":"Nobili","year":"2019"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/cells9010137","article-title":"RNA-based therapeutics: from antisense oligonucleotides to miRNAs","volume":"9","author":"Bajan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0090","first-page":"103","article-title":"Harnessing the therapeutic potential of decoys in non-atherosclerotic cardiovascular diseases: state of the art","volume":"8","author":"Mahjoubin-Tehran","year":"2021","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0095","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.3390\/ijms22094420","article-title":"Decoy technology as a promising therapeutic tool for atherosclerosis","volume":"22","author":"Mahjoubin-Tehran","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5805398","article-title":"Liver protective effect of Fenofibrate in NASH\/NAFLD animal models","volume":"2022","author":"Mahmoudi","year":"2022","journal-title":"PPAR Res"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/nu14204344","article-title":"Effect of curcumin on attenuation of liver cirrhosis via genes\/proteins and pathways: a system pharmacology study","volume":"14","author":"Mahmoudi","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.101365","article-title":"Exploration of the key genes involved in non-alcoholic fatty liver disease and possible microRNA therapeutic targets","author":"Mahmoudi","year":"2024","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0115","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.drudis.2019.04.007","article-title":"Harnessing nucleic acid-based therapeutics for atherosclerotic cardiovascular disease: state of the art","volume":"24","author":"Vahdat Lasemi","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0120","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","article-title":"miRNAs and NAFLD: from pathophysiology to therapy","volume":"68","author":"Gjorgjieva","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.23","article-title":"siRNA versus miRNA as therapeutics for gene silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0130","first-page":"161","article-title":"The role of MicroRNAs in human diseases","volume":"2","author":"Ardekani","year":"2010","journal-title":"Avicenna J Med Biotechnol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0135","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102461","article-title":"MicroRNA-16 inhibits the TLR4\/NF-\u03baB pathway and maintains tight junction integrity in irritable bowel syndrome with diarrhea","volume":"298","author":"Xi","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0145","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11064-018-02714-z","article-title":"MiR-124 enriched exosomes promoted the M2 polarization of microglia and enhanced hippocampus neurogenesis after traumatic brain injury by inhibiting TLR4 pathway","volume":"44","author":"Yang","year":"2019","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0150","first-page":"76","article-title":"MicroRNA-124 alleviates hyperoxia-induced inflammatory response in pulmonary epithelial cell by inhibiting TLR4\/NF-\u03baB\/CCL2","volume":"11","author":"Li","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0155","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s12031-021-01921-8","article-title":"MiR-124 prevents the microglial proinflammatory response by inhibiting the activities of TLR4 and downstream NLRP3 in palmitic acid-treated BV2 cells","volume":"72","author":"Yang","year":"2022","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.736677","article-title":"Analysis of miRNAs profiles in serum of patients with steatosis and Steatohepatitis","volume":"9","author":"Vulf","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.589994","article-title":"Repression of MicroRNA-124-3p alleviates high-fat diet-induced Hepatosteatosis by targeting Pref-1","volume":"11","author":"Wang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0170","doi-asserted-by":"crossref","first-page":"W451","DOI":"10.1093\/nar\/gkl243","article-title":"RNAhybrid: microRNA target prediction easy, fast and flexible","volume":"34","author":"Kr\u00fcger","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0175","doi-asserted-by":"crossref","DOI":"10.1111\/and.14497","article-title":"miR-27 and miR-124 target AR coregulators in prostate cancer: bioinformatics and in vitro analysis","author":"Jafari Najaf Abadi","year":"2022","journal-title":"Andrologia"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0180","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1007\/s13277-015-3057-3","article-title":"MAPK and JAK\/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches","volume":"36","author":"Aghaee-Bakhtiari","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0185","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0190","first-page":"222","article-title":"Determining pro-oxidant antioxidant balance (PAB) and Total antioxidant capacity (TAC) in patients with schizophrenia","volume":"13","author":"Zahedi Avval","year":"2018","journal-title":"Iran J Psychiatry"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0195","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clinbiochem.2006.10.017","article-title":"A novel assay for the evaluation of the prooxidant-antioxidant balance, before and after antioxidant vitamin administration in type II diabetes patients","volume":"40","author":"Alamdari","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.obmed.2020.100272","article-title":"Pro-oxidant\u2013antioxidant balance (PAB) as a prognostic index in assessing the cardiovascular risk factors: a narrative review","volume":"19","author":"Ghazizadeh","year":"2020","journal-title":"Obesity Med"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0205","series-title":"Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome","first-page":"104","volume":"11(1)","author":"Sinton","year":"2019"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0210","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0215","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.beem.2016.11.010","article-title":"MicroRNAs in lipid metabolism and atherosclerosis","volume":"30","author":"Giral","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0220","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tips.2019.02.004","article-title":"Targeting mechanosensitive transcription factors in atherosclerosis","volume":"40","author":"Niu","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0225","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/nar\/gkv050","article-title":"Accurate transcriptome-wide prediction of microRNA targets and small interfering RNA off-targets with MIRZA-G","volume":"43","author":"Gumienny","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111198","article-title":"An update on the role of miR-124 in the pathogenesis of human disorders","volume":"135","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0235","first-page":"29","article-title":"miR-124-3p and miR-140-3p. 2 act as negative regulators of Beclin1 and LC3 expression in the liver of rat model with hepatic impact injury","author":"Niu","year":"2018","journal-title":"Bio Res"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0240","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00011-022-01614-x","article-title":"Increased miR-124-3p alleviates type 2 inflammatory response in allergic rhinitis via IL-4R\u03b1","volume":"71","author":"Liu","year":"2022","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.723625","article-title":"MiR-124-3p suppresses the dysfunction of high glucose-stimulated endothelial cells by targeting G3BP2","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0250","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1096\/fj.201700673r","article-title":"Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons","volume":"32","author":"Huang","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/genes12121852","article-title":"SESN3 inhibited SMAD3 to relieve its suppression for MiR-124, thus regulating pre-adipocyte Adipogenesis","volume":"12","author":"Lin","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-24260-z","article-title":"In silico and in vitro analysis of microRNAs with therapeutic potential in atherosclerosis","volume":"12","author":"Mahjoubin-Tehran","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0265","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00296-018-4218-7","article-title":"MicroRNA-124 inhibits TNF-\u03b1- and IL-6-induced osteoclastogenesis","volume":"39","author":"Ohnuma","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0270","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1002\/jcb.27861","article-title":"miR-124-3p attenuates neuropathic pain induced by chronic sciatic nerve injury in rats via targeting EZH2","volume":"120","author":"Zhang","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0275","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbrc.2022.03.112","article-title":"Roles of miR-124-3p\/Scd1 in urolithin A-induced brown adipocyte differentiation and succinate-dependent regulation of mitochondrial complex II","volume":"606","author":"Li","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0280","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.isci.2018.11.028","article-title":"MicroRNA-124 regulates fatty acid and triglyceride homeostasis","volume":"10","author":"Shaw","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0285","doi-asserted-by":"crossref","first-page":"263","DOI":"10.17219\/acem\/131753","article-title":"miR-124-3p targeting of TGF-\u03b21 inhibits the proliferation of hypertrophic scar fibroblasts","volume":"30","author":"Zhang","year":"2021","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0290","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ydbio.2019.02.010","article-title":"MiR-124 regulates transforming growth factor-\u03b21 induced differentiation of lung resident mesenchymal stem cells to myofibroblast by repressing Wnt\/\u03b2-catenin signaling","volume":"449","author":"Lu","year":"2019","journal-title":"Dev Biol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0295","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.omtn.2016.11.005","article-title":"Reverse expression of aging-associated molecules through transfection of miRNAs to aged mice","volume":"6","author":"Kim","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0300","series-title":"Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers","volume":"8(1)","author":"L\u00f3pez-Riera","year":"2018"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0305","article-title":"Upregulated gga-miR-16-5p inhibits the proliferation cycle and promotes the apoptosis of MG-infected DF-1 cells by repressing PIK3R1-mediated the PI3K\/Akt\/NF-\u03baB pathway to exert anti-inflammatory effect","volume":"20","author":"Zhang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144191","article-title":"MicroRNA 16-5p is upregulated in calorie-restricted mice and modulates inflammatory cytokines of macrophages","volume":"725","author":"Yamada","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119144","article-title":"MiR-15b and miR-16 suppress TGF-\u03b21-induced proliferation and fibrogenesis by regulating LOXL1 in hepatic stellate cells","volume":"270","author":"Ma","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0320","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.biopha.2018.05.041","article-title":"miR-15a\/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-\u03b2 signaling pathway","volume":"104","author":"Jin","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0325","first-page":"247","article-title":"miR-16 mimics inhibit TGF-\u03b21-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells","volume":"39","author":"Wang","year":"2018","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0330","doi-asserted-by":"crossref","first-page":"78566","DOI":"10.18632\/oncotarget.12479","article-title":"Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108664","article-title":"miR-16 inhibits NLRP3 inflammasome activation by directly targeting TLR4 in acute lung injury","volume":"112","author":"Yang","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0340","doi-asserted-by":"crossref","first-page":"19660","DOI":"10.18632\/aging.103997","article-title":"Anticancer effects of miR-124 delivered by BM-MSC derived exosomes on cell proliferation, epithelial mesenchymal transition, and chemotherapy sensitivity of pancreatic cancer cells","volume":"12","author":"Xu","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0345","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12935-022-02754-0","article-title":"A review on the role of mir-16-5p in the carcinogenesis","volume":"22","author":"Ghafouri-Fard","year":"2022","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0350","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/17460441.2020.1765770","article-title":"Challenges identifying efficacious miRNA therapeutics for cancer","volume":"15","author":"Segal","year":"2020","journal-title":"Expert Opin Drug Discovery"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0355","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2147\/DDDT.S288859","article-title":"The risks of miRNA therapeutics: in a drug target perspective","volume":"15","author":"Zhang","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0360","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6889533","article-title":"The role and mechanism of oxidative stress and nuclear receptors in the development of NAFLD","volume":"2021","author":"Hong","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172618","article-title":"Pinolenic acid ameliorates oleic acid-induced lipogenesis and oxidative stress via AMPK\/SIRT1 signaling pathway in HepG2 cells","volume":"861","author":"Zhang","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0370","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.gastrohep.2020.09.014","article-title":"Silencing HIF-1\u03b1 aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-\u03b1\/ANGPTL4 singling pathway","volume":"44","author":"He","year":"2021","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0375","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1134\/S0006297918050127","article-title":"Cytochrome P450 1A1 (CYP1A1) catalyzes lipid peroxidation of oleic acid-induced HepG2 cells","volume":"83","author":"Huang","year":"2018","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0380","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6264474","article-title":"miR-124-3p delivered using exosomes attenuates the keratinocyte response to IL-17A stimulation in psoriasis","volume":"2022","author":"Liu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jdiacomp.2024.108722_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031036","article-title":"miR-16-5p suppression protects human cardiomyocytes against endoplasmic reticulum and oxidative stress-induced injury","volume":"23","author":"Toro","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724000485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724000485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T04:22:31Z","timestamp":1731558151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872724000485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1056872724000485"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108722","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108722","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108722"}}